Karine is a PhD student in the lab of Mike Tyers at the Institute for Research in Immunology and Cancer at the Université de Montréal.

Karine Bourdages now holds a fellowship from the Cole Foundation, a private foundation that funds research in Montréal’s universities and hospitals, aimed at understanding the mechanisms of and curing childhood and young adult leukemias. Karine’s project, entitled “Genome-wide CRISPR gene knock-out collection in human cells,” will work towards identifying new therapeutic targets for cancers bearing mutations in Fbw7, a tumor suppressor gene mutated in 31% of T-cell acute lymphoblastic leukemia.